Could a transplant shield a child’s brain from silent damage compared to standard care? A 10-year study has some answers.

A major review in Leukemia argues the evidence now supports using interferon-alpha as first-line therapy for nearly all PV patients — from diagnosis, not as a last resort.

Hemato-oncology: Defending against blood cancers & disorders, saving lives with expertise & compassion. ️